In the attempt to blockade Nef, we discovered that our CXCR4 antagonists demonstrate profound apoptotic activity against MDA-MB-231 breast cancer cells in vitro similar to the effect of Nef M1 peptide. This evidence concerns the gene CXCR4 and breast cancer.